Sangamo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.About SGMO
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases.
CEOAlexander D. Macrae
CEOAlexander D. Macrae
Employees183
Employees183
HeadquartersRichmond, California
HeadquartersRichmond, California
Founded1995
Founded1995
Employees183
Employees183
SGMO Key Statistics
Market cap184.65M
Market cap184.65M
Price-Earnings ratio-2.21
Price-Earnings ratio-2.21
Dividend yield—
Dividend yield—
Average volume4.19M
Average volume4.19M
High today$0.6299
High today$0.6299
Low today$0.60
Low today$0.60
Open price$0.625
Open price$0.625
Volume1.92M
Volume1.92M
52 Week high$3.18
52 Week high$3.18
52 Week low$0.4111
52 Week low$0.4111
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
33.3%
Sell
0%
People also own
Based on the portfolios of people who own SGMO. This list is generated using Robinhood data, and it’s not a recommendation.